Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,841 | -23,924 | -12,188 | 3,009 | 2,257 |
| Depreciation Amortization | 182 | 119 | 61 | 930 | 284 |
| Accounts receivable | 13,286 | 10,992 | 8,874 | -4,416 | -6,515 |
| Accounts payable and accrued liabilities | -2,920 | N/A | N/A | N/A | 1,229 |
| Other Working Capital | 11,157 | 6,695 | 7,840 | -4,760 | -5,101 |
| Other Operating Activity | -5,333 | -6,610 | -6,691 | 7,165 | 7,769 |
| Operating Cash Flow | $-17,469 | $-12,729 | $-2,103 | $1,927 | $-77 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -419 | -8 | N/A | N/A | N/A |
| Purchase Of Investment | 15,015 | 15,015 | 12,515 | -15,015 | -15,045 |
| Investing Cash Flow | $14,596 | $15,007 | $12,515 | $-15,015 | $-15,045 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 636 | 233 | 92 | 2,719 | 2,162 |
| Other Financing Activity | 0 | 0 | 6 | 0 | 0 |
| Financing Cash Flow | $636 | $233 | $98 | $2,719 | $2,162 |
| Exchange Rate Effect | -241 | -192 | -37 | -28 | -7 |
| Beginning Cash Position | 37,854 | 37,854 | 37,854 | 48,251 | 48,251 |
| End Cash Position | 35,376 | 40,173 | 48,325 | 37,854 | 35,285 |
| Net Cash Flow | $-2,478 | $2,319 | $10,472 | $-10,397 | $-12,967 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,469 | -12,729 | -2,103 | 1,927 | -77 |
| Capital Expenditure | -419 | -8 | N/A | N/A | N/A |
| Free Cash Flow | -17,888 | -12,737 | -2,103 | 1,927 | -77 |